Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rx Dynamic Stock Fund Class C (FMGCX)

Net Asset Value
1 Day
Overall Morningstar Rating
Large growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide investors with long-term capital appreciation. The fund seeks long-term capital appreciation by allocating among a concentrated portfolio of equity positions and cash. Stocks will be evaluated with a growth-oriented approach to selecting the equities of companies that Navellier considers to have superior appreciation potential. Between 0% - 100% of the fund's portfolio will be invested in a maximum of 20 equity securities; between 0% - 100% of the fund's portfolio may be invested in cash and/or short-term investments. It is non-diversified.


1 month-- 3 years--
3 months-- 5 years--
1 year-- Since inception+6.84%
Data through --

Peer Comparisonvs. Large growth

Performance 5-yr return--+9.88%
Expense ratio2.85%1.18%
Risk 5 year sharpe ratio0.370.71
Net assets$13.6M$2.7B
Average market cap$16.0B$84.3B
Average P/E39.321.9
Portfolio turnover120%120%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAmerican Independence
Fund manager & tenureSteven Wruble / 0 Years
Minimal initial investment$5,000.00
Minimum IRA investment--


U.S. stock94.62%
International stock0.00%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Consumer goods 18.56%
Financial service 15.26%
Industrial materials 12.77%
Media 12.57%
Consumer service 11.12%
Top 10 Holdings
Portfolio weighting
ULTA Ulta Salon Cosmetics and Fragrance Inc6.33%
VMC Vulcan Materials Co5.73%
STZ Constellation Brands Inc5.63%
INCY Incyte Corp5.19%
VNTV Vantiv Inc5.17%
EW Edwards Lifesciences Corp5.16%
NI NiSource Inc5.09%
MKTX Marketaxess Holdings Inc5.02%
AYI Acuity Brands Inc4.97%
CMN Cantel Medical Corp4.92%

Partner Offers